Overview
The goal of this clinical trial is to compare two postoperative analgesia strategies in adult women undergoing breast surgery and to evaluate their effects on postoperative pain and quality of recovery after hospital discharge.
The main questions it aims to answer are:
- Does a patient education-based analgesia strategy improve postoperative pain control compared with standard analgesic management?
- Does the patient education-based strategy improve quality of recovery after hospital discharge?
Researchers will compare the patient education group with the standard care group to assess differences in postoperative pain intensity and quality of recovery.
Participants will:
- Receive either a patient education-based postoperative analgesia strategy or standard postoperative analgesic management.
- Complete questionnaires assessing pain, quality of recovery, and other aspects of health at specified time points.
- Be followed for 90 days after surgery.
Description
Postoperative pain following breast surgery can negatively affect patients' recovery and overall experience after hospital discharge. Effective postoperative analgesia may require not only appropriate pharmacological treatment but also adequate patient education regarding pain management and the use of non-pharmacological measures.
This pilot prospective randomized clinical trial is designed to evaluate whether a comprehensive postoperative analgesia strategy incorporating patient education can improve pain control and quality of recovery compared with standard postoperative analgesic management in adult women undergoing breast surgery.
The intervention strategy combines patient education, discussion of postoperative pain management, non-pharmacological measures, and a multimodal pharmacological analgesic regimen. The control strategy consists of standard postoperative analgesic management and written postoperative instructions.
Participants will be followed from the preoperative period through 90 days after surgery to evaluate postoperative pain, quality of recovery, and other patient-reported outcomes.
Eligibility
Inclusion Criteria:
- Age ≥ 18 years
- ASA physical status classification I-III
- Provision of written informed consent
- Ability to be contacted by telephone
Exclusion Criteria:
- Hypersensitivity to any of the medications used in the study
- Severe hepatic or renal dysfunction
- Pregnancy
- History of epileptic seizures
- Severe psychiatric disorder (e.g., active psychosis or severe depression) affecting their ability to cooperate
- Underwent a second surgical procedure before completion of the 3-month follow-up period
